RMCE: Recombinase-Mediated Cassette Exchange

Recombinase-Mediated Cassette Exchange (RMCE) technology enables the swapping of large genomic regions. This technology is mainly recommended for the generation of humanized models and the generation of several mutants using the same parental ES cell clone.

Applications of the RMCE technology.

1) Generation of humanized models using RMCE technology.

RMCE technology allows the substitution of large genomic regions in the mouse genome with the concomitant human genomic regions. RMCE can be easily adapted specifically for the generation of humanized models using genomic DNA. With such an approach a gene of interest and its promoter could be readily humanized in order to reproduce a human expression pattern in the mouse. By using genomic DNA, all human isoforms can theoretically be expressed.

Replacement of a large mouse segment by a human sequence: H.A. Wallace et al. Cell 2006. Manipulating the Mouse Genome to Engineer Precise Functional Syntenic Replacements with Human Sequence.

2) Generation of mutant models for the comparative study of several mutations.

By using RMCE technology, genOway can insert a mutation into a parental ES cell clone. Using the same parental cell clone, we can then readily generate other mutant models, ultimately saving the client time and money.

With this approach researchers are able to compare several mutations by using different targeting vectors in the same parental ES cell clone. These unique mutant cell lines can then be used to create unique mutant mouse lines. Because multiple mutant cell and mouse lines can be created from one parental ES clonal line, RMCE is cost effective and reliable. In addition, RMCE has great potential to allow researchers to comparatively analyze mutants, characterize domain-specific functions in proteins of interest, generate point mutations, generate large gene mutations, and generate entire replacements of a wild type gene with a different gene of interest. In addition, when researchers utilize the same parental ES clonal line, they are able to conduct studies across multiple knock-in models and between different knock-in models.

Replacement of a mouse gene by human variants at high efficiency: C.M. Chen et al. PLoS One 2012. Functional significance of SRJ Domain Mutations in CITED2.

What are the advantages of the RMCE technology?

  • RMCE is quicker and safer than homologous recombination
  • RMCE specifically targets exchanges between two genes
  • RMCE technology can humanize loci by exchanging the mouse gene with the orthologous human gene

How does it work?

RMCE technology is based on generating a parental ES cell line engineered with a transgene that is flanked by specific recombinase sites. genOway then creates a shuttle plasmid containing a second transgene (also flanked by specific recombinase sites). The shuttle plasmid + transgene are transfected into the parental ES line in the presence of a helper plasmid that expresses recombinase. The recombinase catalyzes an exchange between the first ES cell transgene and the shuttle plasmid transgene, thus completing the desired gene transfer.

genOway licenses secure your discoveries and researches.

The RMCE technology was developed by Prof. Philippe Leboulch and Dr. Eric Bouhassira and is patented by the Massachusetts Institute of Technology (MIT) and Albert Einstein College of Medicine of Yeshiva University (AESCOM). The Licensor is Bluebird Bio.

genOway holds an exclusive license for the creation of research models.

The patents covering the Recombinase-Mediated-Cassette-Exchange (RMCE) are issued and maintained in Europe (EP0914457), Japan (JP2010063463), US (US5928914), and Australia (AU733016).

The client will have a permanent, non-exclusive and royalty-free license for the patented and/or proprietary technologies employed to create the rodent model. This guarantees the client full rights to use such a model for any and all R&D purposes.

The client also retains ownership of the deliverables and can patent the model developed. genOway will have no claim on the results generated using the model we provide for you.